We are live on ! Find out more
MAM

Melqart Asset Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 84.85%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+84.85%
3 Year Est. Return
+183.09%
5 Year Est. Return
+319.83%
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
+$92.5M
Cap. Flow
-$8.37M
Cap. Flow %
-0.7%
Top 10 Hldgs %
60.53%
Holding
49
New
22
Increased
3
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$60.6M
2
TIF
Tiffany & Co.
TIF
+$41.5M
3
INXN
Interxion Holding N.V.
INXN
+$40.1M
4
WMGI
Wright Medical Group Inc
WMGI
+$35.8M
5
HGV icon
Hilton Grand Vacations
HGV
+$32.8M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$144M
2
ALDR
Alder Biopharmaceuticals
ALDR
+$50.5M
3
VSM
Versum Materials, Inc.
VSM
+$47.1M
4
NLSN
Nielsen Holdings plc
NLSN
+$36.1M
5
NXPI icon
NXP Semiconductors
NXPI
+$33.1M

Sector Composition

Rank Sector Weight
1 Technology 33.9%
2 Healthcare 25.73%
3 Communication Services 8.97%
4 Consumer Discretionary 7.1%
5 Industrials 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAM icon
26
Atlassian
TEAM
$27.6B
$12.4M 1.04%
103,000
-4,000
-4% -$487K
TWLO icon
27
Twilio
TWLO
$29B
$11.8M 0.99%
120,000
– –
CLF icon
28
Cleveland-Cliffs
CLF
$7.15B
$11.5M 0.97%
+1,382,550
New +$10.6M
FTCH
29
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$11.3M 0.94%
+1,089,000
New +$9.78M
FIT
30
DELISTED
Fitbit, Inc. Class A common stock
FIT
$9.75M 0.82%
+1,484,385
New +$8.71M
QES
31
DELISTED
Quintana Energy Services Inc.
QES
$9.24M 0.77%
3,288,449
– –
ARQL
32
DELISTED
Arqule Inc
ARQL
$7.38M 0.62%
+369,646
New +$4.29M
BMY.RT
33
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$5.42M 0.45%
+1,799,100
New +$4.68M
FIVN icon
34
FIVE9
FIVN
$2.25B
$4.53M 0.38%
69,000
-46,000
-40% -$2.81M
I
35
DELISTED
INTELSAT S. A.
I
$3.94M 0.33%
+560,403
New +$8.81M
I
36
CALL
DELISTED
INTELSAT S. A.
I
$2.89M 0.24%
410,500
-821,000
-67% -$12.9M
CONE
37
DELISTED
CyrusOne Inc Common Stock
CONE
$2.28M 0.19%
34,782
-363,818
-91% -$25M
BOLD
38
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.07M 0.09%
+17,900
New +$672K
ARQL
39
PUT
DELISTED
Arqule Inc
ARQL
$890K 0.07%
+44,600
New +$517K
AMR icon
40
Alpha Metallurgical Resources
AMR
$1.94B
– –
-549,115
Closed -$15.4M
PBYI icon
41
Puma Biotechnology
PBYI
$404M
– –
-529,112
Closed -$5.7M
AY
42
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
– –
-869,936
Closed -$21M
ACIA
43
DELISTED
Acacia Communications Inc
ACIA
– –
-414,579
Closed -$27.1M
PSDO
44
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-1,457,155
Closed -$24.6M
ALDR
45
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-2,680,000
Closed -$50.5M
VSM
46
DELISTED
Versum Materials, Inc.
VSM
– –
-890,000
Closed -$47.1M
NLSN
47
DELISTED
Nielsen Holdings plc
NLSN
– –
-1,701,161
Closed -$36.1M
CELG
48
DELISTED
Celgene Corp
CELG
– –
-1,451,000
Closed -$144M
1
2

Similar funds

WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Melqart Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Melqart Asset Management held 49 positions worth $1.19B, up 8.4% from $1.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Melqart Asset Management's Q4 2019 filing shows 22 new, 3 increased, 10 reduced and 9 closed positions. Its largest new stake was People Inc: 1,502,154 shares worth $66.9M. The largest sale was Celgene Corp, an estimated $144M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Communication Services.

  • Melqart Asset Management's largest Q4 2019 buy was People Inc: 1,502,154 shares worth $66.9M.
  • Melqart Asset Management added most to Vertex Pharmaceuticals in Q4 2019, an estimated $25.9M increase.
  • Melqart Asset Management's biggest Q4 2019 reduction was NXP Semiconductors, cutting an estimated $33.1M.
  • Melqart Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $144M.
  • Melqart Asset Management's ten largest holdings make up 61% of its $1.19B portfolio in Q4 2019.
  • Melqart Asset Management opened 22 new positions and closed 9 in Q4 2019.
  • Melqart Asset Management's portfolio value rose 8.4% quarter-over-quarter to $1.19B.

Based on Melqart Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.